SCM
Soleus Capital Management’s Enliven Therapeutics ELVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-75,405
| Closed | -$1.7M | – | 81 |
|
|
2024
Q4 | $1.7M | Sell |
75,405
-164,300
| -69% | -$3.7M | 0.11% | 68 |
|
|
2024
Q3 | $6.12M | Sell |
239,705
-529,558
| -69% | -$13.5M | 0.47% | 50 |
|
|
2024
Q2 | $18M | Buy |
+769,263
| New | +$18M | 1.59% | 24 |
|